Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Price Down 1% – Here’s What Happened

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX)’s share price fell 1% on Tuesday . The stock traded as low as $3.06 and last traded at $3.06. 314 shares were traded during mid-day trading, a decline of 98% from the average session volume of 16,111 shares. The stock had previously closed at $3.09.

Analyst Ratings Changes

A number of research firms have recently issued reports on EPRX. RODMAN&RENSHAW upgraded shares of Eupraxia Pharmaceuticals to a “strong-buy” rating in a report on Thursday, November 14th. Rodman & Renshaw assumed coverage on shares of Eupraxia Pharmaceuticals in a research note on Thursday, November 14th. They set a “buy” rating and a $9.00 target price on the stock.

Eupraxia Pharmaceuticals Stock Performance

The firm has a 50 day moving average of $3.04 and a 200-day moving average of $2.76. The stock has a market capitalization of $83.48 million and a PE ratio of -4.25.

Eupraxia Pharmaceuticals Company Profile

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company’s lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee.